Vol. 36. No. 3
While various medical specialties treat eczema patients, care for these patients is largely fragmented and disorganized. Moreover, standardized treatment protocols that incorporate upcoming eczema therapies and emerging guidelines have yet to be established. Thus, there is both a need and an opportunity to equip clinicians to succeed in this novel and changing era of eczema care. The National Eczema Association’s (NEA) strategic plan—developed through extensive discussions with patients who have atopic dermatitis and their caregivers, industry, and providers representing different specialties—called for the creation of an interdisciplinary coalition to steer this initiative. The Coalition United for Better Eczema Care (CUBE-C) is a network of cross-specialty leaders working to help construct an educational curriculum based on standards of effective treatment and disease management.
Few studies have compared head-to-head efficacy of the different immunosuppressant therapies such as cyclosporine, methotrexate, azathioprine and mycophenolate mofetil.MORE
We review newly-approved and emerging topical and systemic medications for AD as well as novel early life approaches to preventing the disease onset.MORE
Atopic dermatitis: therapeutic care delivery: therapeutic education, shared decision-making, and access to care
It is important to consider strategies to reduce barriers to cost-effective accessible AD education and treatment.MORE